{
    "organizations": [],
    "uuid": "281c78cd97ca04d5f8bd5a5525e56fa2177e24c3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-parker-hannifins-indego-exoskeleto/brief-parker-hannifins-indego-exoskeleton-receives-fda-clearance-for-stroke-treatment-idUSFWN1Q5160",
    "ord_in_thread": 0,
    "title": "BRIEF-Parker-Hannifin's Indego Exoskeleton Receives FDA Clearance For Stroke Treatment",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Parker-Hannifin Corp:\n* INDEGO® EXOSKELETON RECEIVES U.S. REGULATORY CLEARANCE FOR STROKE TREATMENT\n* PARKER-HANNIFIN - ‍FDA GIVEN ADDITIONAL CLEARANCE TO MARKET & SELL INDEGO EXOSKELETON FOR USE IN TREATMENT OF INDIVIDUALS WITH HEMIPLEGIA DUE TO STROKE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-15T21:50:00.000+02:00",
    "crawled": "2018-02-16T17:02:08.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "corp",
        "exoskeleton",
        "receives",
        "regulatory",
        "clearance",
        "stroke",
        "treatment",
        "given",
        "additional",
        "clearance",
        "market",
        "sell",
        "indego",
        "exoskeleton",
        "use",
        "treatment",
        "individual",
        "hemiplegia",
        "due",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}